Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients.

Trial Profile

Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2014

At a glance

  • Drugs Telmisartan (Primary)
  • Indications Diabetes mellitus; Hyperlipidaemia; Hypertension; Metabolic syndrome
  • Focus Therapeutic Use
  • Acronyms METATEL
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Aug 2011 Results published in the Hypertension.
    • 14 Jul 2010 Actual number of patients (56) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top